Ascendis Pharma A/S

XNAS:ASND

253.86

+1.20 (+0.48%)

7:34:06 PM EDT: $253.86 0.00 (0.00%)

Market Cap (Intraday)	15.84B
Current PE	27.23
Forward PE	15.88
2yr Forward PE	21.51

See more stats

Estimates Current Quarter

Revenue	$376.6 Million
Adjusted EPS	$1.71

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Ascendis Pharma A/S - ADR Stock, XNAS:ASND

Tuborg Boulevard 12, Hellerup, Capital Region 2900

Denmark

Phone: +45.70.22.22.44

Number of Employees:

http://www.ascendispharma.com

Description

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau on September 21, 2006 and is headquartered in Hellerup, Denmark.